Nano Dimension (NNDM) Targets $90 Billion US Diagnostic Market... Bets on AI Preventive Healthcare
3D printing company Nano Dimension is pushing for a merger with Infinite Epigenetics to enter the AI-based preventive healthcare market, targeting the $90 billion US diagnostic market. The combined entity is expected to list on Nasdaq.
Key takeaway
"Nano Dimension (NNDM) Targets $90 Billion US Diagnostic Market... Bets on AI Preventive Healthcare" — BullBear's AI rates this story as a bullish (positive) signal for markets, with a market-impact score of 40 out of 100. 3D printing company Nano Dimension is pushing for a merger with Infinite Epigenetics to enter the AI-based preventive healthcare market, targeting the $90 billion US diagnostic market. The combined entity is expected to list on Nasdaq. Reported by TokenPost on June 15, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bull catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.1%.